Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8343201 | 1.00 | PDE4A (0.67) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL28350552 | 1.00 | PDE4A (0.67) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL29356160 | 1.00 | PDE4A (0.67) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL17144675 | 1.00 | PDE4A (0.67) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL10338405 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL15121486 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL15121487 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5077868 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL725570 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL20591201 | 0.98 | PDE4A (0.64) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 674 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118055752-A | Personal cleansing compositions containing organic acids having pKa greater than 2.7 | 宝洁公司 | 2024-05-17 | — | — | CN | claimed |
| CN-111801088-B | Personal care compositions and uses | 宝洁公司 | 2024-03-08 | — | — | CN | claimed |
| EP-4291155-A1 | MULTI-PHASE SHAMPOO COMPOSITION WITH AN AESTHETIC DESIGN | The Procter & Gamble Company (US) | 2023-12-20 | — | — | EP | claimed |
| CN-117083049-A | Multiphase shampoo compositions with aesthetic design | 宝洁公司 | 2023-11-17 | — | — | CN | claimed |
| CN-112469387-B | Personal cleansing compositions, methods and uses | 宝洁公司 | 2023-07-14 | — | — | CN | claimed |
| US-11684558-B2 | Personal care composition preservatives level optimization | THE PROCTER & GAMBLE COMPANY (US) | 2023-06-27 | — | — | US | claimed |
| CN-111278511-B | Compact shampoo compositions | 宝洁公司 | 2023-06-02 | — | — | CN | claimed |
| WO-2023070501-A1 | PERSONAL CLEANSING COMPOSITION WITH AN ORGANIC ACID HAVING A PKA GREATER THAN 2.7 | THE PROCTER & GAMBLE COMPANY (US) | 2023-05-04 | — | — | WO | claimed |
| US-20230135226-A1 | PERSONAL CLEANSING COMPOSITION WITH AN ORGANIC ACID HAVING A PKA GREATER THAN 2.7 | THE PROCTER & GAMBLE COMPANY | 2023-05-04 | — | — | US | claimed |
| US-11633340-B2 | — | — | 2023-04-25 | — | — | US | claimed |
| CN-101687338-A | Preservative compositions for wood and like materials | GENICS INC | 2010-03-31 | — | — | CN | claimed |
| EP-2117789-A1 | PRESERVATIVE COMPOSITIONS FOR WOOD AND LIKE MATERIALS | Genics, Inc. (CA) | 2009-11-18 | — | — | EP | claimed |
| WO-2008086604-A1 | PRESERVATIVE COMPOSITIONS FOR WOOD AND LIKE MATERIALS | GENICS, INC. (CA) | 2008-07-24 | — | — | WO | claimed |
| US-6712995-B2 | MIXTURE OF ALKANOLAMINE, SURFACTANTS IN AQUEOUS SOLUTION | SIKA SCHWEIZ AG (CH) | 2004-03-30 | — | — | US | claimed |
| EP-0957071-B1 | A method for rehabilitative and/or protective corrosion-inhibition of reinforcing steel embedded in a hardened concrete structure by means of surface-applied corrosion-inhibiting compositions | SIKA SCHWEIZ AG (CH) | 2004-03-24 | — | — | EP | claimed |
| US-20030034479-A1 | Method for rehabilitative and/or protective corrosion-inhibition of reinforcing steel embedded in a hardened concrete structure by means of surface-applied corrosion-inhibiting compositions | SIKA SCHWEIZ AG (CH) | 2003-02-20 | — | — | US | claimed |
| US-6402990-B1 | AMINO- AND/OR HYDROXYALKYLAMINO COMPOUND(S), WHICH ARE PARTIALLY OR COMPLETELY NEUTRALIZED WITH ONE OR MORE INORGANIC ACID(S) AND/OR AROMATIC CARBOXYLIC ACID(S); SURFACTANTS; ORGANOSILICONES AS WATER REPELLENT | SIKA AG, VORM, KASPAR WINKLER & CO. (CH) | 2002-06-11 | — | — | US | claimed |
| US-20020066889-A1 | METHOD FOR REHABILITATIVE AND/OR PROTECTIVE CORROSION-INHIBITION OF REINFORCING STEEL EMBEDDED IN A HARDENED STRUCTURE BY MEANS OF SURFACE-APPLIED CORROSION-INHIBITING COMPOSITIONS | SIKA AG VORM, KASPAR WINKLER & CO. (CH) | 2002-06-06 | — | — | US | claimed |
| EP-0957071-A1 | A method for rehabilitative and/or protective corrosion-inhibition of reinforcing steel embedded in a hardened concrete structure by means of surface-applied corrosion-inhibiting compositions | Sika AG, vorm. Kaspar Winkler & Co. (CH) | 1999-11-17 | — | — | EP | claimed |
| EP-0538193-B1 | Condensed cycloaliphatir-amidino-hydrazon salts as S-adenosylmethionin decarboxylase inhibitors | CIBA GEIGY AG (CH) | 1996-12-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684558-B2 | Personal care composition preservatives level optimization | CUTA, SMURF1, POLR1C | PDE4A 2407/4885LMNA 783/4885L3MBTL1 3751/4885 |
| US-11633340-B2 | — | SMURF1, SUCLG1, S100P | PDE4A 3483/4885LMNA 2102/4885L3MBTL1 3773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.